UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA

Clinical trials for UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Four-Drug cocktail aims to shrink pancreatic tumors before surgery

Disease control Completed

This phase II trial tests whether a combination of four chemotherapy drugs—paclitaxel protein bound, gemcitabine, cisplatin, and hydroxychloroquine—given before surgery can improve outcomes for people with pancreatic cancer that has not spread. The study focuses on patients whose…

Matched conditions: UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA

Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC

UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA

Get alerted when new UNTREATED RESECTABLE PANCREATIC ADENOCARCINOMA trials appear

Four-Drug cocktail aims to shrink pancreatic tumors before surgery